Brief: Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Corporate Update
11/08/2022 14:53
Spectrum Pharmaceuticals Inc SPPI.O :
* SPECTRUM PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 LOSS PER SHARE $0.17
* SPECTRUM PHARMACEUTICALS - CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES BALANCE WAS ABOUT $68 MILLION AT JUNE 30, PROVIDES
FOR CASH RUNWAY INTO 2023
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.17
Source text for Eikon: ID:nBw7h1BQJa
Further company coverage: SPPI.O
Recent news on Spectrum Pharmaceuticals
See all newsBrief: Assertio Holdings Announces Favorable Vote On Proposed Acquisition Of Spectrum Pharmaceuticals
Brief: Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “For” Proposed Deal With Assertio Holdings, Inc.
Brief: Spectrum Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
U.S. RESEARCH ROUNDUP-CTI Biopharma, Park National, Playags
Spectrum Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary